271 related articles for article (PubMed ID: 30411543)
1. Risk factors for brain metastases in patients with non-small-cell lung cancer.
An N; Jing W; Wang H; Li J; Liu Y; Yu J; Zhu H
Cancer Med; 2018 Dec; 7(12):6357-6364. PubMed ID: 30411543
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of risk factors for brain metastases and value of prophylactic cranial irradiation in non-small cell lung cancer.
Sun DS; Hu LK; Cai Y; Li XM; Ye L; Hou HY; Wang CH; Jiang YH
Asian Pac J Cancer Prev; 2014; 15(3):1233-9. PubMed ID: 24606446
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer.
Ding X; Dai H; Hui Z; Ji W; Liang J; Lv J; Zhou Z; Yin W; He J; Wang L
Radiat Oncol; 2012 Jul; 7():119. PubMed ID: 22846375
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial).
Arrieta O; Maldonado F; Turcott JG; Zatarain-Barrón ZL; Barrón F; Blake-Cerda M; Cabrera-Miranda LA; Cardona AF; de la Garza JG; Rosell R
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1442-1450. PubMed ID: 33640422
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.
Sun A; Hu C; Wong SJ; Gore E; Videtic G; Dutta S; Suntharalingam M; Chen Y; Gaspar LE; Choy H
JAMA Oncol; 2019 Jun; 5(6):847-855. PubMed ID: 30869743
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases.
Park HS; Decker RH; Wilson LD; Yu JB
Clin Lung Cancer; 2015 Jul; 16(4):292-7. PubMed ID: 25499149
[TBL] [Abstract][Full Text] [Related]
7. Treatment and toxic effects of prophylactic cranial irradiation in stage II-III non-small cell lung cancer: A meta-analysis.
Li M; Wang T; Wen P; Wang X; Wu C
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e18-e26. PubMed ID: 32761788
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer.
Ouyang W; Yu J; Zhou Y; Hu J; Huang Z; Zhang J; Xie C
BMC Cancer; 2020 Jul; 20(1):699. PubMed ID: 32723319
[TBL] [Abstract][Full Text] [Related]
9. [Present role of prophylactic cranial irradiation].
Le Péchoux C; Al Mohkles H; Dhermain F
Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141
[TBL] [Abstract][Full Text] [Related]
10. The Role of Prophylactic Cranial Irradiation for Non-small Cell Lung Cancer.
Precival C; Landy M; Poole C; Mullaney L
Anticancer Res; 2018 Jan; 38(1):7-14. PubMed ID: 29277750
[TBL] [Abstract][Full Text] [Related]
11. [Research Progress on Risk Factors of Brain Metastasis in Non-small Cell Lung Cancer].
Sun S; Men Y; Hui Z
Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):193-200. PubMed ID: 35340162
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.
De Ruysscher D; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder J; Haitjema T; Ubbels F; Lagerwaard F; El Sharouni SY; Stigt JA; Smit E; van Tinteren H; van der Noort V; Groen HJM
J Clin Oncol; 2018 Aug; 36(23):2366-2377. PubMed ID: 29787357
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients.
Yavuz AA; Topkan E; Onal C; Yavuz MN
J Exp Clin Cancer Res; 2008 Dec; 27(1):80. PubMed ID: 19055787
[TBL] [Abstract][Full Text] [Related]
15. Patient preferences regarding prophylactic cranial irradiation: A discrete choice experiment.
Lehman M; Gorayski P; Watson S; Edeling D; Jackson J; Whitty J
Radiother Oncol; 2016 Nov; 121(2):225-231. PubMed ID: 27717511
[TBL] [Abstract][Full Text] [Related]
16. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma.
Bajard A; Westeel V; Dubiez A; Jacoulet P; Pernet D; Dalphin JC; Depierre A
Lung Cancer; 2004 Sep; 45(3):317-23. PubMed ID: 15301872
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?
Frega S; Bonanno L; Guarneri V; Conte P; Pasello G
Crit Rev Oncol Hematol; 2018 Aug; 128():19-29. PubMed ID: 29958628
[TBL] [Abstract][Full Text] [Related]
18. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases.
Hsiao SH; Chung CL; Chou YT; Lee HL; Lin SE; Liu HE
Lung Cancer; 2013 Nov; 82(2):319-23. PubMed ID: 24018025
[TBL] [Abstract][Full Text] [Related]
19. Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases.
Yu X; Sheng J; Pan G; Fan Y
Int J Cancer; 2021 Sep; 149(5):1121-1128. PubMed ID: 33970485
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]